The MarketReader Minute
💊 Biotech Stocks Struggle as Moderna Partners in Taiwan, Biohaven Launches Public Offering, and Intellia Prepares CRISPR Data Release | Biotech Sector Insights
MRNA's recent partnership with Cenra Healthcare to promote its mRNA respiratory vaccine portfolio in Taiwan being a notable development. Meanwhile, the U.S. Department of Health and Human Services is monitoring supply chain vulnerabilities due to labor disputes at East Coast and Gulf Coast ports.